首页> 外文期刊>Systems biomedicine. >Rank-based transcriptional signatures A novel approach to diagnostic biomarker definition and analysis
【24h】

Rank-based transcriptional signatures A novel approach to diagnostic biomarker definition and analysis

机译:基于等级的转录签名诊断生物标志物定义和分析的新方法

获取原文
       

摘要

We have developed a method for the definition and the analysis of gene expression signatures for diagnostic purposes. Our approach relies on construction of a reference map of transcriptional signatures, from both healthy controls and affected patients, using the respective mRNA or miRNA profiles. Subsequently, disease diagnosis can be performed by determining the relative map position of an individual’s transcriptional signature. Our approach addresses simultaneously the scarce repeatability issue and the high sensitivity of expression profiling methods to protocol variations, thereby providing a novel approach to RNA signature definition and analysis. Specifically, our method requires only that the relative position of RNA species be accurate in a ranking by value, not their absolute values. Furthermore, our method makes no assumptions on which RNA species must be included in the signature and, by considering a large subset (or even the whole set) of known RNAs, our approach can tolerate a moderate number of erroneous inversions in the ranking. The diagnostic power of our method has been convincingly demonstrated in an open scientific competition (sbv IMPROVER Diagnostic Signature Challenge), scoring second place overall, and first place in one sub-challenge. In addition, we report the application of our method to published miRNA expression profile data sets, quantifying its performance in terms of predictive capability and robustness to batch effects, compared with current state-of-the-art methods.
机译:我们已经开发了一种用于诊断目的的基因表达特征的定义和分析方法。我们的方法依赖于使用相应的mRNA或miRNA图谱构建健康对照和受影响患者的转录签名参考图谱。随后,可以通过确定个人转录签名的相对图谱位置来进行疾病诊断。我们的方法同时解决了稀缺的可重复性问题和表达谱分析方法对方案变异的高度敏感性,从而为RNA标记定义和分析提供了一种新颖的方法。具体而言,我们的方法仅要求RNA种类的相对位置在按值(而不是其绝对值)的排序中准确。此外,我们的方法不对签名中必须包括哪种RNA种类做出任何假设,并且通过考虑已知RNA的较大子集(甚至整个集合),我们的方法可以忍受中等数量的错误倒位。我们的方法的诊断能力已在公开的科学竞赛(sbv IMPROVER Diagnostic Signature Challenge)中令人信服地证明了这一点,该技术在整体挑战中获得第二名,并在一项子挑战中获得第一名。此外,我们报告了该方法在已发表的miRNA表达谱数据集上的应用,与目前的最新方法相比,在预测能力和对批次效应的鲁棒性方面对其性能进行了量化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号